aliskiren / amlodipine Oral Tablet
- RxCUI
- 1009218
- RxNorm name
- aliskiren / amlodipine Oral Tablet
- Term type
- SCDF
- Status
- Active
- Updated
- 2026-10-24 12:25:44
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102010
- Active start
- 102010
- Multiple ingredient
- YES
- Branded
- NO
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| amlodipine | 17767 |
| aliskiren | 325646 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| RXNAV_STR | aliskiren / amLODIPine Oral Tablet | 1 | NAMES |
| RxNorm Name | aliskiren / amlodipine Oral Tablet | 1 | NAMES |
| TTY | SCDF | 1 | ATTRIBUTES |
| RxCUI | 1009218 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C08CA | Dihydropyridine derivatives | ATC1-4 | amlodipine | |
| ATC | C09XA | Renin-inhibitors | ATC1-4 | aliskiren | |
| FDASPL | D004095 | Dihydropyridines | CHEM | has_chemical_structure | amlodipine |
| FDASPL | N0000175566 | Calcium Channel Blocker | EPC | has_epc | amlodipine |
| FDASPL | N0000175421 | Dihydropyridine Calcium Channel Blocker | EPC | has_epc | amlodipine |
| FDASPL | N0000175900 | Renin Inhibitor | EPC | has_epc | aliskiren |
| FDASPL | N0000000069 | Calcium Channel Antagonists | MOA | has_moa | amlodipine |
| FDASPL | N0000190114 | Cytochrome P450 3A Inhibitors | MOA | has_moa | amlodipine |
| FDASPL | N0000175899 | Renin Inhibitors | MOA | has_moa | aliskiren |
| MEDRT | D000577 | Amides | CHEM | has_ingredient | aliskiren |
| MEDRT | D017311 | Amlodipine | CHEM | has_ingredient | amlodipine |
| MEDRT | D005650 | Fumarates | CHEM | has_ingredient | aliskiren |
| MEDRT | D013449 | Sulfonamides | CHEM | ci_chemclass | aliskiren |
| MEDRT | D000788 | Angina Pectoris, Variant | DISEASE | may_treat | amlodipine |
| MEDRT | D001002 | Anuria | DISEASE | ci_with | aliskiren |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | aliskiren |
| MEDRT | D003324 | Coronary Artery Disease | DISEASE | may_treat | amlodipine |
| MEDRT | D003920 | Diabetes Mellitus | DISEASE | ci_with | aliskiren |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | amlodipine |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | aliskiren |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | aliskiren |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | amlodipine |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | amlodipine |
| MEDRT | N0000000181 | Angiotensin-converting Enzyme Inhibitors | MOA | ci_moa | aliskiren |
| MEDRT | N0000000181 | Angiotensin-converting Enzyme Inhibitors | MOA | has_moa | aliskiren |
| MEDRT | N0000020065 | L-Calcium Channel Receptor Antagonists | MOA | has_moa | amlodipine |
| MEDRT | N0000175899 | Renin Inhibitors | MOA | ci_moa | aliskiren |
| MEDRT | N0000175899 | Renin Inhibitors | MOA | has_moa | aliskiren |
| MEDRT | N0000008375 | Coronary Arterial Vasodilation | PE | has_pe | amlodipine |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | aliskiren |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | amlodipine |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | ci_pe | amlodipine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| CODES | USP | m6268 |
| NAMES | Tallman Synonym | aliskiren / amLODIPine Oral Tablet |
| SOURCES | Source | United States Pharmacopeia |